Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume 148, Issue -, Pages 239-251Publisher
ELSEVIER
DOI: 10.1016/j.addr.2019.02.007
Keywords
-
Categories
Funding
- National Institutes of Health [R37NS047344, P01NS097206, U19MH106434, R01AG057497, R01MH105128, R35NS097370, U19A1131130]
- NSF
- NIH [T32GM007445]
Ask authors/readers for more resources
The convergence of nanoparticles and stem cell therapy holds great promise for the study, diagnosis, and treatment of neurodegenerative disorders. Researchers aim to harness the power of nanoparticles to regulate cellular microenvironment, improve the efficiency of cell and drug delivery to the brain, and enhance the survival of stem cell transplants. Understanding the various properties of different nanoparticles is key to applying them to clinical therapies; the many distinct types of nanoparticles offer unique capacities for medical imaging, diagnosis, and treatment of neurodegeneration disorders. In this review we introduce the biology of Alzheimer's, Parkinson's Disease, and amyotrophic lateral sclerosis, and discuss the potentials and shortcomings of metal, silica, lipid-based, polymeric, and hydrogel nanoparticles for diagnosis and treatment of neurodegenerative disorders. We then provide an overview of current strategies in stem cell therapies and how they can be combined with nanotechnology to improve clinical outcomes. (C) 2019 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available